2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2018-10-09 c-LEcta accelerates distribution of DENARASE® and signs sales agreement with VWR To continue its growth strategy, c-LEcta is further expanding its track record in the commercialization of its products. In addition to the recent... read more 2018-08-23 c-LEcta lays foundation for further growth and closes financing round c-LEcta already has a diversified shareholder structure. In addition to the founder, Dr. Marc Struhalla, private industrial investors and German... read more 2018-07-26 c-LEcta presented its Bacillus Expression Platform at WCIB 2018 This year’s BIO World Congress on Industrial Biotechnology took place in Philadelphia. Over 1,000 global business leaders, investors and policy makers... read more 2018-06-11 c-LEcta and leading ingredient company develop process to expand production of plant-based sweetener with sugar-like taste The German-based expert for industrial biotechnology applications c-LEcta, in cooperation with a leading ingredient supplier, developed a process... read more 2018-05-24 c-LEcta Reports Financial Results of Business Year 2017 The Leipzig-based industrial biotechnology company has recently closed its financial accounts for last year with very positive outcomes. The company... read more 2018-04-18 EU Approval and Production of c-LEcta’s Trehalose Product TreXalose For its new product TreXaloseTM c-LEcta has reached two important milestones: For the market introduction in Europe the substantial equivalence of... read more 2018-03-06 c-LEcta’s Production Facilities are Certified Kosher and Halal Now After accomplishing several successful projects with global players from the food industry, the upcoming international market launch of the... read more 2018-02-08 c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company As a result of several years of successful collaboration in the field of biocatalysis, c-LEcta and a global leading producer of generic APIs have now... read more